These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3938045)

  • 21. Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
    Takemoto M; Morishita H; Higuchi K; Yoshida J; Aono T
    Hum Reprod; 1994 May; 9(5):800-5. PubMed ID: 7929725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinico-pharmacological investigation of drugs (domperidone, bromocriptine) influencing human prolactin levels from pregnancy to menopause].
    Farkas M
    Acta Pharm Hung; 1993 Nov; 63(6):351-64. PubMed ID: 8116455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of thyrotropin secretion during prolonged administration of exogenous thyrotropin-releasing hormone in normal man.
    Custro N; Scafidi V; Corsello FP
    Boll Soc Ital Biol Sper; 1989 May; 65(5):437-43. PubMed ID: 2505815
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prolactin and the function of the central nervous system].
    Wieniawska-Szewczyk E; Szukalski B
    Psychiatr Pol; 1985; 19(6):466-73. PubMed ID: 2874576
    [No Abstract]   [Full Text] [Related]  

  • 25. Luteinizing hormone response to domperidone in hyperprolactinaemic women with pituitary microadenomas.
    Seki K; Kato K
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):271-5. PubMed ID: 3048796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domperidone directly stimulates TSH secretion in vitro.
    Powell R; White MC; Daniels M; Mashiter K
    FEBS Lett; 1981 Jun; 129(1):97-9. PubMed ID: 6791969
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxytocin does not modify the prolactin response to metoclopramide in normal women.
    Chiodera P; Volpi R; Gramellini D; Cigarini C; Corradi A; Cavazzini U; Bianconi L; Papadia C; Caiazza A; Capretti L
    J Endocrinol Invest; 1991 Jun; 14(6):463-8. PubMed ID: 1774442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses of luteinizing hormone, follicle-stimulating hormone, and prolactin to prolonged administration of the dopamine antagonist in normal women and women with low-weight amenorrhea.
    Larsen S
    Fertil Steril; 1981 Jun; 35(6):642-6. PubMed ID: 6788608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further analysis of the positive feedback effects of estrogen on the release of gonadotropin in women.
    Araki S; Akabori A; Minakami H; Chikazawa K; Tamada T
    Endocrinol Jpn; 1980 Dec; 27(6):709-16. PubMed ID: 6790267
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.
    Brown TE; Fernandes PA; Grant LJ; Hutsul JA; McCoshen JA
    J Soc Gynecol Investig; 2000; 7(1):65-9. PubMed ID: 10732318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in pituitary hormone levels induced by met-enkephalin in man--the role of dopamine.
    Delitala G; Grossman A; Besser GM
    Life Sci; 1981 Oct; 29(15):1537-44. PubMed ID: 6795405
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of 17 beta-estradiol on serum protlactin levels and on prolactin responses to thyrotropin-releasing hormone in female rhesus monkeys.
    Quadri SK; Oyama T; Spies HG
    Endocrinology; 1979 Jun; 104(6):1649-55. PubMed ID: 109283
    [No Abstract]   [Full Text] [Related]  

  • 33. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)].
    Bercovici JP; Khoury S; Tater D; Besson G; Caroff J
    Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin secretion from clonal pituitary cells following incubation with estradiol, progesterone, thyrotrophin releasing hormone and dopamine.
    Herbert DC; Ishikawa H; Shino M; Rennels EG
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):605-9. PubMed ID: 418418
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormone release.
    Steele MK; McCann SM; Negro-Vilar A
    Endocrinology; 1982 Sep; 111(3):722-9. PubMed ID: 7106048
    [No Abstract]   [Full Text] [Related]  

  • 36. [Promoting lactation with the aid of drugs].
    Sondervan-Frank BS
    Ned Tijdschr Geneeskd; 1987 Jun; 131(26):1112-7. PubMed ID: 3112590
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative evaluation of the prolactinogenic activity of domperidone and metoclopramide by the study of the pituitary prolactin reserve].
    Nardoni A; Marchetti E; Di Piazza V; Treleani M; Geatti O
    Clin Ter; 1986 Jul; 118(1):19-22. PubMed ID: 3742972
    [No Abstract]   [Full Text] [Related]  

  • 38. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
    Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF
    J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolactin secretion in the sterile male].
    Grizard G; Boucher D; Hermabessière J
    Gynecologie; 1977; 28(5):421-8. PubMed ID: 414942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.